These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 18164667)

  • 1. Treatment of cardiovascular dysfunction associated with the metabolic syndrome and type 2 diabetes.
    Oltman CL; Kleinschmidt TL; Davidson EP; Coppey LJ; Lund DD; Yorek MA
    Vascul Pharmacol; 2008 Jan; 48(1):47-53. PubMed ID: 18164667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of vascular/neural dysfunction in Zucker rats treated with enalapril or rosuvastatin.
    Oltman CL; Davidson EP; Coppey LJ; Kleinschmidt TL; Lund DD; Yorek MA
    Obesity (Silver Spring); 2008 Jan; 16(1):82-9. PubMed ID: 18223617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of coronary and mesenteric vascular dysfunction in Zucker obese and Zucker diabetic fatty rats.
    Oltman CL; Richou LL; Davidson EP; Coppey LJ; Lund DD; Yorek MA
    Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1780-7. PubMed ID: 16714356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance, oxidative stress, and podocyte injury: role of rosuvastatin modulation of filtration barrier injury.
    Whaley-Connell A; DeMarco VG; Lastra G; Manrique C; Nistala R; Cooper SA; Westerly B; Hayden MR; Wiedmeyer C; Wei Y; Sowers JR
    Am J Nephrol; 2008; 28(1):67-75. PubMed ID: 17914247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 diabetes severely impairs structural and functional adaptation of rat resistance arteries to chronic changes in blood flow.
    Belin de Chantemèle EJ; Vessières E; Guihot AL; Toutain B; Maquignau M; Loufrani L; Henrion D
    Cardiovasc Res; 2009 Mar; 81(4):788-96. PubMed ID: 19050009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of voltage-dependent erectile responses in the Zucker obese-diabetic rat by rosuvastatin-altered RhoA/Rho-kinase signaling.
    Wingard CJ; Moukdar F; Prasad RY; Cathey BL; Wilkinson L
    J Sex Med; 2009 Mar; 6 Suppl 3(Suppl 3):269-78. PubMed ID: 19267849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of rosuvastatin on endothelial function in patients with familial combined hyperlipidaemia (FCH).
    ter Avest E; Abbink EJ; Holewijn S; de Graaf J; Tack CJ; Stalenhoef AF
    Curr Med Res Opin; 2005 Sep; 21(9):1469-76. PubMed ID: 16197666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats.
    Oltman CL; Coppey LJ; Gellett JS; Davidson EP; Lund DD; Yorek MA
    Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E113-22. PubMed ID: 15727946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary vascular dysfunction promoted by oxidative-nitrative stress in SHRSP.Z-Lepr(fa) /IzmDmcr rats with metabolic syndrome.
    Kagota S; Fukushima K; Umetani K; Tada Y; Nejime N; Nakamura K; Mori H; Sugimura K; Kunitomo M; Shinozuka K
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1035-43. PubMed ID: 20659132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk between cardiomyocyte-rich perivascular tissue and coronary arteries is reduced in the Zucker Diabetic Fatty rat model of type 2 diabetes mellitus.
    Bonde L; Shokouh P; Jeppesen PB; Boedtkjer E
    Acta Physiol (Oxf); 2017 Jan; 219(1):227-238. PubMed ID: 27042951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosuvastatin prevents angiotensin II-induced vascular changes by inhibition of NAD(P)H oxidase and COX-1.
    Colucci R; Fornai M; Duranti E; Antonioli L; Rugani I; Aydinoglu F; Ippolito C; Segnani C; Bernardini N; Taddei S; Blandizzi C; Virdis A
    Br J Pharmacol; 2013 Jun; 169(3):554-66. PubMed ID: 22817606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosuvastatin increases vascular endothelial PPARgamma expression and corrects blood pressure variability in obese dyslipidaemic mice.
    Desjardins F; Sekkali B; Verreth W; Pelat M; De Keyzer D; Mertens A; Smith G; Herregods MC; Holvoet P; Balligand JL
    Eur Heart J; 2008 Jan; 29(1):128-37. PubMed ID: 18063594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the HMG-CoA reductase inhibitor rosuvastatin on early chronic kidney injury in obese zucker rats fed with an atherogenic diet.
    Reisin E; Ebenezer PJ; Liao J; Lee BS; Larroque M; Hu X; Aguilar EA; Morse SA; Francis J
    Am J Med Sci; 2009 Oct; 338(4):301-9. PubMed ID: 19826320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats.
    Okada Y; Yamaguchi K; Nakajima T; Nishikawa T; Jo M; Mitsumoto Y; Kimura H; Nishimura T; Tochiki N; Yasui K; Mitsuyoshi H; Minami M; Kagawa K; Okanoue T; Itoh Y
    Liver Int; 2013 Feb; 33(2):301-11. PubMed ID: 23295058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosuvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats.
    Habibi J; Whaley-Connell A; Qazi MA; Hayden MR; Cooper SA; Tramontano A; Thyfault J; Stump C; Ferrario C; Muniyappa R; Sowers JR
    Endocrinology; 2007 May; 148(5):2181-8. PubMed ID: 17317778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes.
    Bellia A; Rizza S; Galli A; Fabiano R; Donadel G; Lombardo MF; Cardillo C; Sbraccia P; Tesauro M; Lauro D
    Atherosclerosis; 2010 May; 210(1):199-201. PubMed ID: 20018286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of captopril and enalapril in obese Zucker rats.
    Duarte J; Martinez A; Bermejo A; Vera B; Gámez MJ; Cabo P; Zarzuelo A
    Eur J Pharmacol; 1999 Jan; 365(2-3):225-32. PubMed ID: 9988106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular and neural dysfunction in Zucker diabetic fatty rats: a difficult condition to reverse.
    Oltman CL; Davidson EP; Coppey LJ; Kleinschmidt TL; Lund DD; Adebara ET; Yorek MA
    Diabetes Obes Metab; 2008 Jan; 10(1):64-74. PubMed ID: 17970755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of statins on vascular endothelial function in hypercholesterolemic patients with type 2 diabetes mellitus: fluvastatin vs. rosuvastatin.
    Tomizawa A; Hattori Y; Suzuki K; Okayasu T; Kase H; Satoh H; Kasai K
    Int J Cardiol; 2010 Sep; 144(1):108-9. PubMed ID: 19174316
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.